Neurotez Inc.

Neurotez Inc. is developing a drug to treat Leptin deficiency in Alzheimer’s patients.

Closed

February 26, 2018

science

platform logo

Total raised

updated 359 days ago

$95,209

19%

Funding goal

$10K- $500K

Minimum ticket

$ 1.00

Investors

Regulation

County Flag
C

EQUITY

Share price

$1

Number of securities

5,000

Discover our exclusive features for registered users

Understand when and how people have invested in a campaign with our hourly commitments and investor data.

Benefit from AI-powered company descriptions and other important information.

Access financial statements from various sources in one convenient location.

No subscription required - Wixdom is and will remain free to use! Register now to access our industry-leading crowdfunding data.

Sign up for free

Available soon

© 2020-2022 COLLISIO TECHNOLOGIES S.L.